Bradley Foster & Sargent Inc Vertex Pharmaceuticals Inc Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 1,796 shares of VRTX stock, worth $733,091. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,796

Previous 1,896 5.27%

Holding current value

$733,091

Previous $888,000 5.97%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$460.0 - $505.78 $46,000 - $50,578	-100 Reduced 5.27%	1,796 $835,000
Q2 2024 Aug 09, 2024	BUY	$392.81 - $485.53 $15,712 - $19,421	40 Added 2.16%	1,896 $888,000
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $360,397 - $394,334	-884 Reduced 32.26%	1,856 $775,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $18,865 - $22,587	55 Added 2.05%	2,740 $1.11 Million
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $4,087 - $4,574	13 Added 0.49%	2,685 $944,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $2,857 - $3,214	-10 Reduced 0.37%	2,672 $771,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $33,954 - $37,885	124 Added 4.85%	2,682 $777,000
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $181,389 - $225,848	772 Added 43.23%	2,558 $721,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $13,728 - $16,180	62 Added 3.6%	1,786 $466,000
Q4 2021 Mar 11, 2022	SELL	$177.01 - $223.45 $72,574 - $91,614	-410 Reduced 19.21%	1,724 $379,000
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $17.9 Million - $20 Million	-98,754 Reduced 97.88%	2,134 $387,000
Q2 2021 Aug 19, 2021	BUY	$187.49 - $221.1 $143,054 - $168,699	763 Added 0.76%	100,888 $20.3 Million
Q1 2021 Apr 26, 2021	BUY	$207.02 - $241.31 $19.9 Million - $23.2 Million	96,333 Added 2540.43%	100,125 $21.5 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $77,007 - $102,705	372 Added 10.88%	3,792 $896,000
Q4 2019 Jan 29, 2020	BUY	$166.71 - $223.91 $104,860 - $140,839	629 Added 22.54%	3,420 $749,000
Q3 2019 Oct 30, 2019	BUY	$166.23 - $187.09 $149,440 - $168,193	899 Added 47.52%	2,791 $473,000
Q2 2019 Aug 08, 2019	SELL	$164.61 - $190.37 $102,881 - $118,981	-625 Reduced 24.83%	1,892 $347,000
Q1 2019 May 02, 2019	BUY	$163.73 - $194.7 $2,783 - $3,309	17 Added 0.68%	2,517 $463,000
Q4 2018 Jan 30, 2019	BUY	$151.91 - $192.21 $127,148 - $160,879	837 Added 50.33%	2,500 $414,000
Q2 2018 Jul 31, 2018	BUY	$145.72 - $169.96 $31,038 - $36,201	213 Added 14.69%	1,663 $283,000
Q1 2018 May 07, 2018	BUY	$151.6 - $177.13 $219,820 - $256,838	1,450 New	1,450 $236,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Vertex Pharmaceuticals Inc Transaction History